We are live on ! Find out more
BMO

Beck Mack & Oliver Portfolio holdings

AUM $4.85B
1-Year Est. Return 9.66%
This Fund
S&P 500
This Quarter Est. Return
+7.71%
1 Year Est. Return
+9.66%
3 Year Est. Return
+69.39%
5 Year Est. Return
+96.17%
10 Year Est. Return
+350.87%
AUM
$5.4B
AUM Growth
+$262M
Cap. Flow
-$15.9M
Cap. Flow %
-0.29%
Top 10 Hldgs %
47.35%
Holding
199
New
22
Increased
52
Reduced
70
Closed
9

Top Buys

Rank Stock Value
1
CSGP icon
CoStar Group
CSGP
+$43.2M
2
FERG icon
Ferguson
FERG
+$11.5M
3
SDHC icon
Smith Douglas Homes
SDHC
+$8.54M
4
MTDR icon
Matador Resources
MTDR
+$5.05M
5
ROP icon
Roper Technologies
ROP
+$3.11M

Top Sells

Rank Stock Value
1
EPD icon
Enterprise Products Partners
EPD
+$35.3M
2
APO icon
Apollo Global Management
APO
+$18.4M
3
RDNT icon
RadNet
RDNT
+$9.55M
4
SHW icon
Sherwin-Williams
SHW
+$8.93M
5
ESGR
Enstar Group
ESGR
+$8.67M

Sector Composition

Rank Sector Weight
1 Financials 43.35%
2 Healthcare 13.58%
3 Technology 11.42%
4 Industrials 7.55%
5 Communication Services 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMT icon
176
American Tower
AMT
$83.5B
– –
-1,063
Closed -$247K
AZN icon
177
AstraZeneca
AZN
$269B
– –
-1,357
Closed -$211K
BSX icon
178
Boston Scientific
BSX
$68.4B
– –
-5,026
Closed -$421K
GEHC icon
179
GE HealthCare
GEHC
$32.7B
– –
-2,553
Closed -$240K
LUMN icon
180
Lumen
LUMN
$6.43B
– –
-22,923
Closed -$163K
MRSH
181
Marsh
MRSH
$94.3B
– –
-1,100
Closed -$245K
VCMP
182
DELISTED
VCAMPUS CORP
VCMP
$0 ﹤0.01%
59,956
– –
4 5 6 7
8

Similar funds

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
MCCA
Mill Creek Capital Advisors Conshohocken, Pennsylvania $4.87B AUM 17.69% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $4.82B AUM 15.21% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
JSTA
Japan Science & Technology Agency Tokyo, Japan $4.81B AUM 4.62% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
KCM
Kensico Capital Management Greenwich, Connecticut $4.9B AUM 41.26% 1-Year Est. Return

Beck Mack & Oliver's Q4 2024 Portfolio in Review

As of Q4 2024, Beck Mack & Oliver held 199 positions worth $5.4B, up 5.1% from $5.14B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Beck Mack & Oliver's Q4 2024 filing shows 22 new, 52 increased, 70 reduced and 9 closed positions. Its largest new stake was Oracle: 4,017 shares worth $669K. The largest sale was Enterprise Products Partners, an estimated $35.3M.

By sector, the portfolio is most concentrated in Financials at 43% of assets, up from 41% a quarter earlier, followed by Healthcare and Technology.

  • Beck Mack & Oliver's largest Q4 2024 buy was Oracle: 4,017 shares worth $669K.
  • Beck Mack & Oliver added most to CoStar Group in Q4 2024, an estimated $43.2M increase.
  • Beck Mack & Oliver's biggest Q4 2024 reduction was Enterprise Products Partners, cutting an estimated $35.3M.
  • Beck Mack & Oliver fully exited Boston Scientific in Q4 2024, selling an estimated $421K.
  • Beck Mack & Oliver's ten largest holdings make up 47% of its $5.4B portfolio in Q4 2024.
  • Beck Mack & Oliver opened 22 new positions and closed 9 in Q4 2024.
  • Beck Mack & Oliver's portfolio value rose 5.1% quarter-over-quarter to $5.4B.

Based on Beck Mack & Oliver's 13F filing for Q4 2024, filed 13 Feb 2025.